Growth Metrics

BioNTech SE (BNTX) EBIT Margin (2018 - 2025)

BioNTech SE (BNTX) posted EBIT Margin of 35.57% for Q4 2025, down 1052.1% on a QoQ basis from 3.09% in Q3 2025, and down 4806.0% year-over-year from 0.76% in Q4 2024.

BioNTech SE (BNTX) has 8 years of EBIT Margin data on file, last reported at 35.57% in Q4 2025.

  • In Q4 2025, EBIT Margin fell 4806.0% year-over-year to 35.57%; the TTM figure through Dec 2025 stood at 46.98% (up 240.0% YoY), while the FY2025 annual figure was 48.95%, up 119095.0% from the prior year.
  • EBIT Margin slipped to 35.57% in Q4 2025, from 3.09% in the prior quarter.
  • Across five years, EBIT Margin topped out at 84.95% in Q4 2021 and bottomed at 2945.73% in Q2 2024.
  • A 5-year average of 167.71% and a median of 24.03% in 2023 frame the typical range for EBIT Margin.
  • Annual changes were most pronounced in 2024 — EBIT Margin sank 260983 bps — and 2025, when it soared 275359 bps.
  • Year by year, EBIT Margin stood at 84.95% in 2021, then decreased by 9 bps to 76.97% in 2022, then tumbled by 54 bps to 35.58% in 2023, then plunged by 65 bps to 12.49% in 2024, then plunged by 385 bps to 35.57% in 2025.
  • The last three EBIT Margin figures came in at 35.57% (Q4 2025), 3.09% (Q3 2025), and 192.14% (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -6.43%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 38.10%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 17.83%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 23.02%
10 BioNTech SE 27.66 Bn 7.53 Bn 668.28 Mn -35.57%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -35.57%
Sep 30, 2025 -3.09%
Jun 30, 2025 -192.14%
Mar 31, 2025 -2,302.16%
Dec 31, 2024 4,503.03%
Sep 30, 2024 0.84%
Jun 30, 2024 -2,945.73%
Mar 31, 2024 -5,513.04%
Dec 31, 2023 35.58%
Sep 30, 2023 8.16%
Jun 30, 2023 -335.90%
Mar 31, 2023 51.25%
Dec 31, 2022 76.97%
Sep 30, 2022 68.98%
Jun 30, 2022 69.13%
Mar 31, 2022 74.56%
Dec 31, 2021 84.95%
Sep 30, 2021 77.60%
Jun 30, 2021 79.09%
Mar 31, 2021 81.15%
Dec 31, 2020 70.70%
Sep 30, 2020 276.15%
Jun 30, 2020 193.72%
Mar 31, 2020 214.08%
Sep 30, 2019 128.65%
Jun 30, 2019 185.64%
Mar 31, 2019 167.60%
Dec 31, 2018 0.08%
Sep 30, 2018 0.00%